Tag: biotech

Whose Genes Are They Anyway? The Murky Waters of Genetic Data Ownership

Whose Genes Are They Anyway? The Murky Waters of Genetic Data Ownership

The rise of direct-to-consumer genetic testing (DTC-GT) companies like 23andMe and Ancestry has opened a Pandora's Box of ethical questions, chief among them: who truly owns your genetic data once you spit into that tube? As a journalist who has followed the tech and bioethics beat for years, I've seen...

23andMe's DNA Dilemma: What Bankruptcy Means for Your Genetic Data

23andMe's DNA Dilemma: What Bankruptcy Means for Your Genetic Data

23andMe, the leading light of the genetic testing and personal genomics revolution, took an exhilarating step forward this past week. This momentous announcement has already been making waves throughout the industry. Its March 23, 2025 announcement that it has entered Chapter 11 bankruptcy. This decision is a welcome relief after...

23andMe Files for Bankruptcy Amid Data Privacy Concerns, Urges Customers to Delete Data

23andMe Files for Bankruptcy Amid Data Privacy Concerns, Urges Customers to Delete Data

23andMe, the California-based personal genomics company, has today made a formal Chapter 11 bankruptcy protection filing. This decision deepens uncertainty about the long-term fate of its extensive genetic database. The company has faced recent and unprecedented scrutiny by the public for its data privacy practices. Now, as part of the...

23andMe Seeks Sale Through Bankruptcy After Data Breach Settlement

23andMe Seeks Sale Through Bankruptcy After Data Breach Settlement

23andme, the consumer genomics company, is seeking protection under Chapter 11 bankruptcy laws. This move is merely another step in their scheme to sell the company. This decision comes on the heels of a March 2023 data breach that impacted 6.9 million customers and a buyout offer that was turned...

Genetics on the Brink? Navigating the Future After 23andMe's Troubles

Genetics on the Brink? Navigating the Future After 23andMe's Troubles

It’s a difficult time to be in the personal genetics industry, a point underscored by the recent financial turmoil at 23andMe. 23andMe is considered the biggest player in the direct-to-consumer (DTC) genetic testing market. Their plight raises important questions, not just about the safety and privacy of individual genetic information....

Decoding Disaster 23andMe's Wake-Up Call for Genetic Data Security

Decoding Disaster 23andMe's Wake-Up Call for Genetic Data Security

The recent data breach at 23andMe, affecting millions of users, isn't just a technological hiccup. It's a blaring alarm about the lax regulations governing our most personal information: our genetic code. As a long-time journalist covering tech, I would say that I understand both the promise of and peril posed...